ETC
FATE icon

Exchange Traded Concepts’s Fate Therapeutics FATE Stock Holding History

Exchange Traded Concepts’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-131,830
Closed -$104K – 1436
2025
Q1 		$104K Buy
131,830
+89,541
+212% +$110K ﹤0.01% 1149
2024
Q4 		$69.8K Hold
42,289
– – ﹤0.01% 1195
2024
Q3 		$148K Buy
42,289
+12,230
+41% +$47.6K ﹤0.01% 1072
2024
Q2 		$98.6K Sell
30,059
-9,351
-24% -$40.9K ﹤0.01% 940
2024
Q1 		$289K Sell
39,410
-24,315
-38% -$151K 0.01% 812
2023
Q4 		$238K Buy
63,725
+16,159
+34% +$38.1K 0.01% 773
2023
Q3 		$101K Buy
47,566
+21,955
+86% +$72.7K ﹤0.01% 891
2023
Q2 		$122K Sell
25,611
-196,990
-88% -$1.09M ﹤0.01% 905
2023
Q1 		$1.27M Buy
222,601
+181,304
+439% +$1.09M 0.03% 289
2022
Q4 		$417K Buy
41,297
+10,186
+33% +$191K 0.01% 556
2022
Q3 		$697K Sell
31,111
-5,739
-16% -$166K 0.02% 322
2022
Q2 		$913K Buy
36,850
+2,586
+8% +$71.4K 0.03% 306
2022
Q1 		$1.33M Buy
34,264
+4,465
+15% +$173K 0.03% 283
2021
Q4 		$1.74M Buy
29,799
+5,201
+21% +$295K 0.03% 256
2021
Q3 		$1.46M Buy
+24,598
New +$1.93M 0.04% 266
2021
Q2 		– Sell
-2,039
Closed -$168K – 1147
2021
Q1 		$168K Sell
2,039
-9,103
-82% -$872K 0.01% 676
2020
Q4 		$1.01M Sell
11,142
-6,818
-38% -$423K 0.05% 225
2020
Q3 		$718K Buy
+17,960
New +$627K 0.04% 211

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Exchange Traded Concepts's FATE Position: Q2 2025 in Review

Exchange Traded Concepts sold out of Fate Therapeutics (FATE) in Q2 2025, closing a stake of 131,830 shares — an estimated $104K sold.

Exchange Traded Concepts first reported a position in FATE in Q3 2020 and held it in 18 quarters. The position peaked at $1.74M in Q4 2021. 139 funds tracked by Wall St. Rank hold FATE as of Q2 2025.

  • Exchange Traded Concepts reported no remaining Fate Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Exchange Traded Concepts sold 131,830 Fate Therapeutics shares in Q2 2025, an estimated $104K.
  • Exchange Traded Concepts first reported a position in Fate Therapeutics in Q3 2020 and held it in 18 quarters.
  • Exchange Traded Concepts's Fate Therapeutics position peaked at $1.74M in Q4 2021.
  • 139 funds tracked by Wall St. Rank held Fate Therapeutics as of Q2 2025.

Based on Exchange Traded Concepts's 13F filing for Q2 2025, filed 10 Jul 2025.